|
|
Year 2016 - Volume 36, Number 11
|
|
Safety and immunogenicity of a glycoprotein E gene-deleted bovine herpesvirus 1 strain as a candidate vaccine strain, 36(11):1067-1074
|
ABSTRACT.- Weiss M., Anziliero D., Martins M., Weiblen R. & Flores E.F. 2016. Safety and immunogenicity of a glycoprotein E gene-deleted bovine herpesvirus 1 strain as a candidate vaccine strain. Pesquisa Veterinária Brasileira 36(11):1067-1074. Setor de Virologia, Departamento de Medicina Veterinária Preventiva, Universidade Federal de Santa Maria, Av. Roraima 1000, Santa Maria, RS 97105-900, Brazil. E-mail: eduardofurtadoflores@gmail.com
A glycoprotein E-deleted Brazilian bovine herpesvirus 1 (BoHV-1gE∆) was tested regarding to safety and immunogenicity. Intramuscular inoculation of young calves with a high virus dose did not result in clinical signs or virus shedding during acute infection or after dexamethasone administration. Calves vaccinated once IM (group I) or subcutaneously (group II) with live BoHV-1gEΔ or twice with inactivated virus plus aluminum hydroxide (group IV) or MontanideTM (group V) developed VN titers of 2 to 8 (GMT:2); 2 to 4 (GMT:1.65); 2 to 16 (GMT:2.45) and 2 to 128 (GMT:3.9), respectively. All BoHV-1gEΔ vaccinated calves remained negative in an anti-gE ELISA. Lastly, six young calves vaccinated with live BoHV-1gE∆ and subsequently challenged with a virulent BoHV-1 strain shed less virus and developed only mild and transient nasal signs comparing to unvaccinated calves. Thus, the recombinant BoHV-1gE∆ is safe and immunogenic for calves and allows for serological differentiation by a gE-ELISA test. |
|
|
|
|
|
|